GL Capital on its proposed privatization of SciClone Pharmaceuticals (Holdings) Limited (HKSE: 6600), a company incorporated in the Cayman Islands and listed on the Hong Kong Stock Exchange
Archer Capital, an independent Australian private equity firm, on the formation of Archer Capital Fund 5 (A$1.5 billion) and Archer Capital Growth Fund 2 (A$300 million)
C-Bridge Capital in the formation of its fourth flagship healthcare buyout fund
CD Capital, a specialist natural resources and mining private equity manager, in the formation of its third private equity fund (c. US$355 million)
Centurium Capital in the formation of Centurium Capital Partners 2018 (US$2 billion)
Creador, an independent South East Asia private equity firm, in the formation of its Fund V (US$671 million); Fund IV (US$650 million); Fund III (c. US$415 million)
Crescent Point Group, a South East Asia investment firm specializing in special situations investments, on the formation of its (i) consumer and special opportunities private sleeve fund (US$198 million) and (ii) consumer and special opportunities institutional sleeve fund (US$165 million)
Dayone Capital in the formation of its first USD fund of over US$630 million
EMR Capital, a specialist mining private equity manager, in the formation of its second private equity fund (c. US$860 million)
Hammer Capital on its investment fund structure in respect of an announced take-private transaction by an investor consortium (of which Hammer Capital is a member, the other member being Tencent Holdings (HKSE: 700)), to acquire Bitauto Holdings Limited (NYSE: BITA) at US$1.1 billion, and the consequential mandatory general offer for the shares of Yixin Group Limited (HKSE: 2858) valued at US$1.6 billion pursuant to the chain principle under the Hong Kong Takeovers Code
Hidden Hill Capital in the formation of its Fund I (US$600 million) and Foundation Fund (US$500 million)
Hosen Capital in the formation of its Fund III (US$800 million)
L Catterton in its GP-led secondary transaction and formation of L Catterton Asia 3 Continuation Fund. This transaction was named Secondaries Deal of the Year in Asia by The PEI Awards 2022.
L Catterton in the formation of L Catterton Asia 3 (US$1.45 billion) and L Capital Asia 2 (c. US$1 billion)
L Catterton on its US$250 million investment in Jio Platforms, a next-generation Indian technology company and subsidiary of Reliance Industries. This transaction was named TMT Deal of the Year by The Asia Legal Awards 2021
A top-tier China Healthcare Manager in the formation of LAV Fund VI (US$1.35 billion); Fund V (US$750 million); Fund IV (US$450 million); Fund III (US$300 million)
Ocean Link in the formation of its second USD fund, Ocean Link Fund II (US$580 million)
Olympus Capital Asia in the $450 million restructuring of Olympus Capital Asia's third fund
Orchid Asia, an independent Chinese private equity firm, in the formation of its seventh private equity fund (c. US$1.3 billion) and its sixth private equity fund (c. US$920 million)
Pacific Road Capital Management, a specialist mining private equity firm, on the formation of Pacific Road Resources Fund II (US$475 million)
PAG in the formation of PAG Asia III (US$6 billion)
Panacea Venture in the formation of its Fund I (US$180 million); Fund II (over US$276 million)
Saratoga Capital, an independent Indonesian private equity firm, on the formation of Saratoga Asia III (US$600 million)
The Growth Fund, an independent Australian private equity firm, on the formation of The Growth Fund 3 (A$450 million)
Vision Knight Capital, an independent Chinese private equity firm, in the formation of its second China private equity fund (US$550 million)
